Cilofungin (LY121019) shows nonlinear plasma pharmacokinetics and tissue penetration in rabbits
- PMID: 2073114
- PMCID: PMC172029
- DOI: 10.1128/AAC.34.11.2240
Cilofungin (LY121019) shows nonlinear plasma pharmacokinetics and tissue penetration in rabbits
Abstract
We studied the plasma pharmacokinetics and tissue penetration of cilofungin (LY121019), a new echinocandin antifungal compound, by intermittent and continuous infusion in rabbits. Following a single intravenous dose of 50 mg/kg of body weight, the maximum concentration in plasma was 297 +/- 39 micrograms/ml, the area under the curve was 30.1 +/- 6.7 micrograms.h/ml, clearance was 30 +/- 10 ml/min/kg, volume of distribution was 0.85 +/- 0.23 liters/kg, half-life in distribution phase was 3.7 +/- 0.2 min (first 12 min postdose), and half-life in elimination phase was 12.9 +/- 0.7 min. When rabbits received cilofungin by continuous infusion (CI) at 10 mg/kg/h over 6 days, sustained concentrations in plasma of 290 +/- 56 micrograms/ml were seen, more than 50-fold higher than predicted if kinetics were linear. Similarly, at 5 mg/kg/h, high levels were also obtained. Such elevated levels in plasma would not have been predicted from the pharmacokinetic characteristics of cilofungin given as a single intravenous dose. Further pharmacokinetic study at several rates of CI suggested that cilofungin elimination follows Michaelis-Menten kinetics. Simultaneous cilofungin levels in plasma and tissue were then determined for rabbits receiving six intravenous, intermittent doses (ID) of cilofungin at 15 mg/kg every 4 min and for rabbits receiving CI as described above. After ID, the mean of the ratios of cilofungin levels in tissue to those in plasma were highest for liver and bile but very low for cerebrum and cerebellum. After CI, ratios were as much as 89 times higher than for ID and significantly greater in the brain, choroid, kidney, and bile (P less than 0.05). We conclude that following a single dose of cilofungin, the compound is rapidly cleared via first-order kinetics and does not penetrate into the central nervous system, whereas following CI, cilofungin exhibits nonlinear saturable kinetics, is slowly cleared, and significantly penetrates into central nervous system tissues.
Similar articles
-
Efficacy of cilofungin therapy administered by continuous intravenous infusion for experimental disseminated candidiasis in rabbits.Antimicrob Agents Chemother. 1992 Jan;36(1):56-8. doi: 10.1128/AAC.36.1.56. Antimicrob Agents Chemother. 1992. PMID: 1590700 Free PMC article.
-
Antifungal effects of the nonlinear pharmacokinetics of cilofungin, a 1,3-beta-glucan synthetase inhibitor, during continuous and intermittent intravenous infusions in treatment of experimental disseminated candidiasis.Antimicrob Agents Chemother. 1991 Jul;35(7):1321-8. doi: 10.1128/AAC.35.7.1321. Antimicrob Agents Chemother. 1991. PMID: 1929288 Free PMC article.
-
Compartmental pharmacokinetics and tissue distribution of the antifungal echinocandin lipopeptide micafungin (FK463) in rabbits.Antimicrob Agents Chemother. 2001 Dec;45(12):3322-7. doi: 10.1128/AAC.45.12.3322-3327.2001. Antimicrob Agents Chemother. 2001. PMID: 11709303 Free PMC article.
-
[Clinical pharmacokinetics of azlocillin].Presse Med. 1984 Mar 29;13(13):788-96. Presse Med. 1984. PMID: 6231596 Review. French.
-
Single or 2-Dose Micafungin Regimen for Treatment of Invasive Candidiasis: Therapia Sterilisans Magna!Clin Infect Dis. 2015 Dec 1;61 Suppl 6:S635-42. doi: 10.1093/cid/civ715. Clin Infect Dis. 2015. PMID: 26567282 Review.
Cited by
-
Pharmacokinetic and pharmacodynamic modeling of anidulafungin (LY303366): reappraisal of its efficacy in neutropenic animal models of opportunistic mycoses using optimal plasma sampling.Antimicrob Agents Chemother. 2001 Oct;45(10):2845-55. doi: 10.1128/AAC.45.10.2845-2855.2001. Antimicrob Agents Chemother. 2001. PMID: 11557479 Free PMC article.
-
Efficacy of cilofungin therapy administered by continuous intravenous infusion for experimental disseminated candidiasis in rabbits.Antimicrob Agents Chemother. 1992 Jan;36(1):56-8. doi: 10.1128/AAC.36.1.56. Antimicrob Agents Chemother. 1992. PMID: 1590700 Free PMC article.
-
Preliminary animal pharmacokinetics of the parenteral antifungal agent MK-0991 (L-743,872).Antimicrob Agents Chemother. 1997 Nov;41(11):2339-44. doi: 10.1128/AAC.41.11.2339. Antimicrob Agents Chemother. 1997. PMID: 9371330 Free PMC article.
-
Dosage-dependent antifungal efficacy of V-echinocandin (LY303366) against experimental fluconazole-resistant oropharyngeal and esophageal candidiasis.Antimicrob Agents Chemother. 2001 Feb;45(2):471-9. doi: 10.1128/AAC.45.2.471-479.2001. Antimicrob Agents Chemother. 2001. PMID: 11158743 Free PMC article.
-
Systemically administered antifungal agents. A review of their clinical pharmacology and therapeutic applications.Drugs. 1992 Jul;44(1):9-35. doi: 10.2165/00003495-199244010-00002. Drugs. 1992. PMID: 1379913 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources